GO
Loading...

Medimmune Explores Options

Thursday, 12 Apr 2007 | 9:13 AM ET

Medimmune is evaluating takeover offers and has hired Goldman Sachs to help it explore its options. CNBC's David Faber has more on this and an update on Dow Chemical.